CONMED Corporation
CNMD
$52.29
$1.142.23%
NYSE
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 3.94% | 4.32% | 5.00% | 10.23% | 12.02% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 3.94% | 4.32% | 5.00% | 10.23% | 12.02% |
| Cost of Revenue | 2.71% | 2.36% | 2.61% | 6.70% | 8.71% |
| Gross Profit | 4.92% | 5.88% | 6.94% | 13.18% | 14.79% |
| SG&A Expenses | 5.79% | 4.67% | 2.58% | 6.41% | 7.11% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 3.94% | 3.31% | 2.64% | 6.67% | 7.85% |
| Operating Income | 3.94% | 12.59% | 25.57% | 47.89% | 59.70% |
| Income Before Tax | 11.13% | 39.96% | 101.70% | 440.63% | 394.82% |
| Income Tax Expenses | 8.65% | 23.66% | 86.96% | 199.88% | 140.01% |
| Earnings from Continuing Operations | 11.77% | 44.20% | 105.44% | 127.25% | 11.68% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 11.77% | 44.20% | 105.44% | 127.25% | 11.68% |
| EBIT | 3.94% | 12.59% | 25.57% | 47.89% | 59.70% |
| EBITDA | 3.29% | 8.51% | 16.67% | 28.75% | 34.50% |
| EPS Basic | 11.32% | 43.61% | 104.60% | 125.66% | 10.69% |
| Normalized Basic EPS | 8.63% | 20.25% | 39.16% | 82.57% | 102.14% |
| EPS Diluted | 12.39% | 45.55% | 107.80% | 126.86% | 10.75% |
| Normalized Diluted EPS | 10.12% | 22.49% | 41.82% | 85.33% | 103.37% |
| Average Basic Shares Outstanding | 0.49% | 0.51% | 0.57% | 0.66% | 0.79% |
| Average Diluted Shares Outstanding | -0.88% | -1.38% | -1.23% | -0.50% | 0.43% |
| Dividend Per Share | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Payout Ratio | -0.10% | -0.30% | -0.51% | -0.56% | -0.10% |